Alteogen signs deal with Novartis worth up to $3.2 bil. for subcutaneous formulations - koreatimes.co.kr
The Korea Times
·
2026.09.02
·
2026.09.02 07:16
·
👁 3
Alteogen signs deal with Novartis worth up to $3.2 bil. for subcutaneous formulations koreatimes.co.kr
원문 기사 읽기
news.google.com
이 기사 공유하기
관련 기사
일반
Samsung Electronics, LG Electronics win 11 innovation awards at IFA 2026
일반
Foreign ministry lifts travel alerts for parts of Thailand, 3 other countries
일반
3 ex-prosecutors, 1 former judge shortlisted for new investigative agency chief
일반